Longevity Acquisition Corporation announced that on October 21, 2020, it entered into an Agreement and Plan of Merger with 4D Pharma PLC and Dolphin Merger Sub Limited. Concurrent with the execution of the Merger Agreement and the receipt of the proceeds from the Note, Teddy Zheng resigned from his positions of Chief Financial Officer. On the same date, the Board appointed Matthew Chen as CFO.